Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update

Second Quarter Financial Results Conference Call

Aug 14, 2026 • 8:00am EDT

18th Biennial Congress of the Anaerobe Society of the Americas

Jul 8 – Jul 10, 2026